APBI 2016
Less local treatment: where is the limit? Side effects
Continuation of tamoxifen treatment after adjuvant tamoxifen for 1–4 years may provide Japanese breast cancer patients with better HRQOL than by switching to anastrozole.
Ohsumi S, et al. Breast Cancer Res Treat. 2011;127:143–152
Made with FlippingBook